Abstract

Faced with the need to find new drugs for all kinds of diseases, science sees that Nature offers numerous classes of compounds showing an impressively high biological potential. Among those are the cyclodepsipeptides, hybrid structures composed of amino and hydroxy acids. In the past decades numerous cyclodepsipeptides have been isolated and their potential as drugs has been studied extensively. For several cyclodepsipeptides total syntheses both in solution and on solid-phase have been established, allowing the production of combinatorial libraries. In addition, the biosynthesis of specific cyclodepsipeptides has been elucidated and used for the chemoenzymatic preparation of nonnatural analogues. This review summarizes the recent literature on cyclic tetra- to decadepsipeptides, composed exclusively of α-amino- and α-hydroxy acids.

Highlights

  • Cyclodepsipeptides constitute a large family of peptide-related natural products consisting of hydroxy and amino acids linked by amide and ester bonds

  • In the living cell cyclodepsipeptides are synthesized by giant multi-domain nonribosomal peptide synthetases (NRPs), following the so-called thiol template mechanism which features the domain organization C1-A1-T1-C2-A2-MT-T2a-T2b (Figure 1)

  • In 1989 the Waki group presented a total synthesis of AM-toxin II (2) and [L-Phe3]AM-toxin II (8), an analogue of 2, in which L-2-amino-5-phenylpentanoic acid was replaced for a L-Phe (Scheme 1) [22]

Read more

Summary

Introduction

Cyclodepsipeptides constitute a large family of peptide-related natural products consisting of hydroxy and amino acids linked by amide and ester bonds. The cyclic nature and frequent N-methylation of amino acid residues confer resistance to hydrolyzing enzymes which results in enhanced oral bioavailability. Due to their unique structural and biological properties cyclodepsipeptides have emerged as promising lead structures for applications in crop protection (enniatins) as well as in human (aureobasidine) and veterinary medicine (PF1022). The use of large excesses of hydroxy acids in the coupling reaction is hampered by their high prices and limited availability compared to ribosomal amino acids. For other classes of depsipeptides the reader is referred to more specific literature [9,10,11,12]

Biosynthesis of Cyclodepsipeptides
AM-Toxins
H N SeO O
Cyclopentadepsipeptides
Alternaramide
Zygosporamide
Enniatins and Beauvericin
Synthesis of Enniatins and Enniatin Derivatives
Biosynthesis of Enniatins and Beauvericin
Beauvenniatins
Hirsutellide A
Kutznerides
Monamycins
Himastatin
Paecilodepsipeptide A and Conoideocrellide A
Pullularins A-E
Hirsutatins A and B
HUN-7293
Bassianolide
Verticlide
PF1022A and Emodepside
Syntheses of PF1022A
Synthesis of PF1022A-Analogues via Total Synthesis
PF1022A Analogues by Direct Derivatization of the Natural Product
Biosynthesis of PF1022A
Mode of Action of PF1022A and Emodepside
BZR-cotoxins I-IV
Clavariopsin A and B
Findings
10. Summary
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call